Funding · Healthcare & Life Sciences

Articulus Surgical raises undisclosed seed funding from Kalaari Capital

By Startup Enthusiast · 11 February 2026

What they do

Articulus Surgical builds indigenous robotic platforms for minimally invasive surgeries in India

The company raised undisclosed seed funding led by Kalaari Capital with other backers

Funds will accelerate deployments and training as India's robotic surgery penetration remains under 1%

Articulus Surgical has raised undisclosed seed funding from Kalaari Capital.
The investment was led by Pranav Koshal, vice president at Kalaari Capital.
Other investors include Gaurav Agarwal and Sandeep Daga.
The startup plans to use the funds to expand its market presence over the next 12-18 months.
It aims to deepen hospital partnerships and increase surgeon training programs.
The company focuses on general surgery, gynaecology, urology, gastrointestinal surgery, and surgical oncology.
Its flagship product Pulsar is currently undergoing clinical validation before commercial deployment.
The company also offers Galaxi, an intelligent surgical optics robot, and Nebula, a training platform.

India's robotic surgery penetration is currently under 1%, indicating significant room for growth.
Global robotic surgery penetration stands at approximately 5-6%, showing a broader adoption trend.
Over 200 million abdominal surgeries are performed annually worldwide, highlighting the large addressable market.
The company designs systems specifically for smaller, resource-constrained Indian operating rooms.

Articulus Surgical builds an indigenous surgical robotics ecosystem for soft-tissue surgeries.
Its design philosophy targets smaller and resource-constrained Indian operating rooms.
The flagship product Pulsar is a compact modular robotic platform for abdominal and pelvic surgeries.
Pulsar is currently undergoing clinical validation ahead of commercial deployment.
The company offers Galaxi, which is an intelligent surgical optics robot.
Nebula is a robotic surgery training and simulation platform currently in production.
Nebula is already being deployed commercially at teaching hospitals and medical colleges.
The company operates an R&D facility and manufacturing unit in Bengaluru.
Founder Saurya Mishra established the company in 2019 to address local healthcare needs.

Kalaari Capital (Lead Investor) — Venture capital firm led by Pranav Koshal.
Gaurav Agarwal (Backer) — Cofounder and Managing Director of Innvolution Healthcare.
Sandeep Daga (Backer) — Managing Director of Nine Rivers Capital.

Product: Interoperable surgical robotics ecosystem for minimally invasive soft-tissue surgery with India-built platform
Customers: Hospitals and surgeons seeking advanced minimally invasive surgical capabilities across diverse healthcare settings
How it makes money: Hospital deployment model with partnerships for surgeon training and long-term engagement
What sets it apart: India-built make-in-India solution targeting 200+ million annual abdominal surgeries with less than 1% robotic penetration in India